Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa (MENA) region. Its GM, Zeina Sfeir Lahoud, discusses the company’s presence in over 17 countries, their 25 years of experience in Saudi Arabia, and the dynamics shaping the largest market in the region, including the fast regulatory approval process in place. With value-based healthcare an increasingly hot topic, she explains how Biologix has moved to sign the first risk-sharing agreement with Saudi Arabia for a spinal muscular atrophy product; the first in the MENA region.
STAY UP TO DATE NEWS & EVENTS
Related EVENTS & NEWS
Biologix at the 7th Omani Society of Hematology & 16th Arab Transfusion Medicine Forum
Biologix Hybrid Kickoff Meeting 2022
Joining forces for a cleaner tomorrow - Biologix partners with DGrade
On Thursday 4 May, Biologix held a "Plastic 101" session, at our offices in Dubai Science Park, to educate our employees on the importance of plastic recycling followed by a recycling activity that involved plastic sorting.
